Specifically, miR-29 plays a role in downregulating genes like CLDN1 and NKRF, which can lead to increased intestinal permeability, a phenomenon observed in studies on knockout mice and tissue samples from IBS patients. This evidence concerns the gene CLDN1 and irritable bowel syndrome.